CSIMarket
 




Revolution Medicines Inc   (RVMD)
Other Ticker:  
 
 



RVMD Price to Cash Flow Ratio (Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Cash Flow Trailing 12 Months III. Quarter II. Quarter I. Quarter IV. Quarter III. Quarter
Price to Cash Flow (TTM) Ratio current            24.28            10.00            6.73            36.03            34.77
Cashflow TTM Y / Y Change 257.08 % - % - % 983.88 % -21.53 %
Cashflow Y / Y Change - % - % - % - % - %
Stock performance to date 27.08 % 10.06 % -13.26 % 28.62 % 2.22 %

Price to Cash Flow ratio Comment
Company's current Price to Cash Flow ratio has increased due to shareprice growth of 27.08 %, from beginning of III. Quarter and due to Cash flow increase, to Price to Cash Flow of 24.28, from average Price to Cash Flow ratio in II. Quarter of 10.00.


What is Price to Cash Flow Ratio?
Valuation in Biotechnology & Pharmaceuticals Industry

Price to Cash Flow ratio Company Ranking
Within: No.
Industry #0
Sector #7
S&P 500 #57






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com